Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated With Infliximab, Etanercept And Adalimumab In Nordic Setting
Abstract
Authors
SB Gokhale T Cassel R Mahon PE Balkin S Singh S Bhattacharyya J Handin C Mendoza